ViiV Healthcare, Medicines Patent Pool extend voluntary licensing to enable access to HIV treatment Read more
Gilead Sciences signs licencing agreements with six companies to manufacture, commercialise Lenacapavir Read more
Viatris gets tentative nod from US FDA for Abacavir/Dolutegravir/Lamivudine to treat paediatric HIV patients Read more